Washington, DC, United States of America

James B Delehanty

This inventor holds 21 USPTO granted patents and 5 published patent applications and 3 EPO patents, primarily in Nanoparticle Technology. Top assignees: USA as Represented by Secretary of the Navy, The University of Chicago. Active years: 2013-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James B Delehanty. Retrieved from https://idiyas.com/inventor/james-b-delehanty

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 (Patent Applications = 5)

% Patents Active = 85.7

EPO Patents = 3 (Patent Applications = 7)

Average Co-Inventor Count = 5.8

ph-index = 2

Forward Citations = 12(Granted Patents)

Company Filing History:

21 out of 16,278

USA as Represented by Secretary of the Navy

patents

2 out of 965

The University of Chicago

patents

where one patent can have more than one assignee

Years Active: 2013-2026

Loading Chart...

Areas of Expertise:

Cobalt-Porphyrin Complexes

Nanoplasmonic Sensors

Drug Delivery Applications

Cellular Membrane Potential

Quantum Dots

Gold Nanoflowers

Peptide Delivery

Bioimaging Techniques

Potassium Channel Blockers

Extracellular Analyte Concentration

Bioconjugates

Proanthocyanidins

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12734146 - Cobalt-porphyrin complexes for the inactivation of the biological activity of opioids (2026-09-15),

2. 12624347 - Wireless Activation of Channelrhodopsin via In Situ Self-assembly of Semiconductor Quantum Dots at the Plasma Membrane (2026-05-12),

3. 12485484 - Seedless synthesis of anisotropic gold nanoflowers with cellular control and drug delivery applications (2025-12-02),

4. 12007328 - Determining extracellular analyte concentration with nanoplasmonic sensors (2024-06-11),

5. 11878064 - Nanoparticle/peptide method of blocking potassium channels (2024-01-23),

6. 11744834 - Metal-porphyrin complexes for the inactivation of the biological activity of opioids (2023-09-05),

7. 11617800 - Nanoparticle-enhanced activity of a potassium channel-blocking peptide (2023-04-04),

8. 11287430 - Modular, multifunctional nanoparticle-based bioconjugate for realtime visualization of cellular membrane potential (2022-03-29),

9. 10780185 - Multifunctional nanoparticle bioconjugates for photoacoustic-based recording of cellular membrane potential (2020-09-22),

10. 10761028 - Determining extracellular analyte concentration with nanoplasmonic sensors (2020-09-01),

11. 10705092 - Modular, multifunctional nanoparticle-based bioconjugate for realtime visualization of cellular membrane potential (2020-07-07),

12. 10641705 - Nanoplasmonic imaging technique for the spatio-temporal mapping of single cell secretions in real time (2020-05-05),

13. 10183080 - Use of single dendritic wedge cell penetrating peptides to facilitate cellular delivery of nanoparticles and nanoparticles carrying cargos (2019-01-22),

14. 9880149 - Coatings of semiconductor quantum dots for improved visibility of electrodes and pipettes (2018-01-30),

15. 9791368 - Nanosplasmonic imaging technique for the spatio-temporal mapping of single cell secretions in real time (2017-10-17),

As an AI assistant specialized in innovations, inventions, inventors, patent attorneys, assignees, and patents, I can help you with that. Here is the article about inventor James B. Delehanty:

Title: Innovator Spotlight: James B. Delehanty

Introduction:

James B. Delehanty, a talented inventor based in Washington, DC, has made significant contributions to the field of extracellular analyte concentration determination and nanoparticle/peptide methods for blocking potassium channels.

Latest Patents:

With an impressive portfolio of 18 patents, Delehanty's recent groundbreaking inventions include "Determining Extracellular Analyte Concentration with Nanoplasmonic Sensors" and "Nanoparticle/Peptide Method of Blocking Potassium Channels".

Career Highlights:

Delehanty's innovative approach to determining extracellular concentration data of analytes involves utilizing sensor data from functionalized plasmonic nanostructures on a localized surface plasmon resonance imaging chip. His work has paved the way for more accurate and efficient data collection methods in this crucial field.

Collaborations:

Throughout his career, Delehanty has collaborated with esteemed professionals, including Jeffrey R. Deschamps and Igor L. Medintz. His collaborations have led to the development of cutting-edge technologies and methodologies in the realm of bioanalytical chemistry.

Conclusion:

In conclusion, James B. Delehanty's exceptional work in the invention and patent space has positioned him as a pioneer in the field of extracellular analyte concentration determination. His dedication to innovation and collaboration underscores his commitment to advancing scientific research and technological development.

If you need further information or assistance on innovations, inventions, inventors, patent attorneys, assignees, or patents, feel free to ask!

Profile summary based on public USPTO records.